Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis

Cladribine tablets; Relapsing multiple sclerosis; Treatment satisfaction

Bibliographic Details
Authors:	Montalban Gairín, Xavier, Solari, Alessandra, Brochet, Bruno, Langdon, Dawn, Piehl, Fredrik, Lechner-Scott, Jeannette, Hupperts, Raymond
Format:	article
Status:	Published version
Publication Date:	2021
Country:	España
Institution:	Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:	Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:	oai:recercat.cat:11351/7836
Online Access:	https://hdl.handle.net/11351/7836 http://hdl.handle.net/11351/7836
Access Level:	Open access
Keyword:	Esclerosi múltiple - Tractament Pacients - Satisfacció Qualitat de vida - Avaluació DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Relapsing-Remitting Other subheadings::Other subheadings::Other subheadings::/drug therapy ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple recurrente-remitente Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

Description
Summary:	Cladribine tablets; Relapsing multiple sclerosis; Treatment satisfaction